Abridge, San Francisco, CA-based supplier of a generative AI platform for medical conversations, raised $250M in Collection D funding.
The spherical was co-led by Elad Gil and IVP, with participation from Bessemer Enterprise Companions, California Well being Care Basis, CapitalG, CVS Well being Ventures, Ok. Ventures, Lightspeed Enterprise Companions, NVentures, Redpoint Ventures, Spark Capital, and SV Angel
The corporate intends to make use of the funds to additional improve extra improvement of AI capabilities and industrial progress to assist broader purposes.
Abridge was based in 2018 to empower understanding in healthcare. Its AI platform transforms medical conversations into clinically helpful and billable documentation on the level of care, decreasing administrative burden and clinician burnout whereas enhancing affected person expertise. With the EHR integration, assist for 28+ languages, and 50+ specialties, it’s used throughout a variety of care settings, together with outpatient, emergency division, and inpatient.
Supported by Linked Proof, Abridge supplies an answer that maps AI-generated summaries to supply knowledge, serving to clinicians rapidly belief and confirm the output.
The Abridge Contextual Reasoning Engine allows:
- Contextual consciousness past the dialog: integrating knowledge from retrospective affected person encounters, well being system-specific income cycle tips, and clinician documentation preferences to create extra complete, customized notes.
- Exact downside detection: intelligently recognizing and grouping medical issues, describing them with language that aligns with acceptable billing codes to simplify downstream income cycle workflows.
- Actionable outputs: capturing medical orders and integrating them into the digital well being document, prepared for clinician evaluate.
- Auditable notes: tying AI-generated outputs to supply info throughout all enter knowledge—powered by Linked Proof.
FinSMEs
17/02/2025
